The DOI matches its Crossref record; 283 of the 283 references it cites were found in a registry or an index.
The Role of Natural Killer Cells in Autoimmune Diseases
Open accessAbstract
Natural killer (NK) cells, the large granular lymphocytes differentiated from the common lymphoid progenitors, were discovered in early 1970’s. They are members of innate immunity and were initially defined by their strong cytotoxicity against virus-infected cells and by their important effector functions in anti-tumoral immune responses. Nowadays, NK cells are classified among the recently discovered innate lymphoid cell subsets and have capacity to influence both innate and adaptive immune responses. Therefore, they can be considered as innate immune cells that stands between the innate and adaptive arms of immunity. NK cells don’t express T or B cell receptors and are recognized by absence of CD3. There are two major subgroups of NK cells according to their differential expression of CD16 and CD56. While CD16+CD56 dim subset is best-known by their cytotoxic functions, CD16-CD56 bright NK cell subset produces a bunch of cytokines comparable to CD4+T helper cell subsets. Another subset of NK cells with production of interleukin (IL)-10 was named as NK regulatory cells, which has suppressive properties and could take part in immune-regulatory responses. Activation of NK cells is determined by a delicate balance of cell-surface receptors that have either activating or inhibitory properties. On the other hand, a variety of cytokines including IL-2, IL-12, IL-15, and IL-18 influence NK cell activity. NK-derived cytokines and their cytotoxic functions through induction of apoptosis take part in regulation of the immune responses and could contribute to the pathogenesis of many immune mediated diseases including ankylosing spondylitis, Behçet’s disease, multiple sclerosis, rheumatoid arthritis, psoriasis, systemic lupus erythematosus and type-1 diabetes. Dysregulation of NK cells in autoimmune disorders may occur through multiple mechanisms. Thanks to the rapid developments in biotechnology, progressive research in immunology enables better characterization of cells and their delicate roles in the complex network of immunity. As NK cells stand in between innate and adaptive arms of immunity and “bridge” them, their contribution in inflammation and immune regulation deserves intense investigations. Better understanding of NK-cell biology and their contribution in both exacerbation and regulation of inflammatory disorders is a requisite for possible utilization of these multi-faceted cells in novel therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–283 of 283
Thanapati, S., Ganu, M. A., Giri, P. S., Kulkarni, S. P., Sharma, M., Babar, P., Ganu, A., & Tripathy, A. S. (2017) · Human Immunology · doi:10.1016/j.humimm.2017.02.006 · Cited by 82
Caspase-8 regulation of TRAIL-mediated cell death.
Crowder, R. N., & El‐Deiry, W. S. (2012) · PubMed · Cited by 80
Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis
Rodríguez, J., López‐Botet, M., Munteis, E., Río, J., Roquer, J., Montalbán, X., & Comabella, M. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.09.006 · Cited by 78
Distinct HLA-C/KIR Genotype Profile Associates with Guttate Psoriasis
Holm, S. J., Sakuraba, K., Mallbris, L., Wolk, K., Ståhle, M., & Sánchez, F. O. N. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23879.x · Cited by 76
Ready for Prime Time: NK Cell Priming by Dendritic Cells
Long, E. O. (2007) · Immunity · doi:10.1016/j.immuni.2007.04.001 · Cited by 76
Sivori, S., Carlomagno, S., Moretta, L., & Moretta, A. (2006) · European Journal of Immunology · doi:10.1002/eji.200535781 · Cited by 76
Cytokine-Mediated Activation of NK Cells during Viral Infection
Freeman, B. E., Raué, H.-P., Hill, A. B., & Slifka, M. K. (2015) · Journal of Virology · doi:10.1128/jvi.00199-15 · Cited by 75
Lo, C. K. C., Lam, Q. L. K., Sun, L., Wang, S., Ko, K., Huaxi, X., Wu, C. Y., Zheng, B., & Lu, L. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23760 · Cited by 75
Lack of NK cells in lupus patients with renal involvement
Erkeller-Yüksel, F., Lydyard, P. M., & Isenberg, D. A. (1997) · Lupus · doi:10.1177/096120339700600905 · Cited by 74
Contributions of B cells to lupus pathogenesis
Sang, A. L., Zheng, Y.-Y., & Morel, L. M. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.11.013 · Cited by 72
T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities
Casciano, F., Pigatto, P. D. M., Secchiero, P., Gambari, R., & Reali, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01390 · Cited by 72
Peripheral NK cell phenotypes: multiple changing of faces of an adapting, developing cell
PERUSSIA, B., Chen, Y., & Loza, M. J. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.017 · Cited by 71
Killer immunoglobulin‐like receptor ligand HLA‐Bw4 protects against multiple sclerosis
Lorentzen, Å. R., Karlsen, T. H., Olsson, M., Smestad, C., Mero, I., Woldseth, B., Sun, J., Senitzer, D., Celius, E. G., Thorsby, E., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21695 · Cited by 71
Kallionpää, H., Somani, J., Tuomela, S., Ullah, U., de Albuquerque, R., Lönnberg, T., Komsi, E., Siljander, H., Honkanen, J. K., Härkönen, T., et al. (2019) · Diabetes · doi:10.2337/db19-0287 · Cited by 71
Ahern, D., & Brennan, F. (2011) · Immunology Letters · doi:10.1016/j.imlet.2010.11.001 · Cited by 70
The Development and Diversity of ILCs, NK Cells and Their Relevance in Health and Diseases
Zhang, Y., & Huang, B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_11 · Cited by 69
Natural killer cells control a T-helper 1 response in patients with Behçet's disease
Yamaguchi, Y., Takahashi, H., Satoh, T., Okazaki, Y., Mizuki, N., Takahashi, K., Ikezawa, Z., & Kuwana, M. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3005 · Cited by 68
Multiple sclerosis: an example of pathogenic viral interaction?
Fierz, W. (2017) · Virology Journal · doi:10.1186/s12985-017-0719-3 · Cited by 67
IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets
Laroni, A., Gandhi, R., Beynon, V., & Weiner, H. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026173 · Cited by 61
The roles for innate lymphoid cells in the human immune system
Mazzurana, L., Rao, A., Acker, A. V., & Mjösberg, J. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0688-7 · Cited by 61
NK cell-mediated lysis of autologous human oligodendrocytes
Arbing, R. H. A., Seguin, R. M., McCrea, E., & Antel, J. P. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00289-2 · Cited by 60
Innate Lymphocytes in Psoriasis
Polese, B., Zhang, H., Thurairajah, B., & King, I. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00242 · Cited by 60
Chalan, P., Bijzet, J., Kroesen, B., Boots, A. M. H., & Brouwer, E. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.150644 · Cited by 57
The innovative development in interferon beta treatments of relapsing‐remitting multiple sclerosis
Madsen, C. (2017) · Brain and Behavior · doi:10.1002/brb3.696 · Cited by 56
Pesce, S., Squillario, M., Greppi, M., Loiacono, F., Moretta, L., Moretta, A., Sivori, S., Castagnola, P., Barla, A., Candiani, S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02360 · Cited by 55
Lau, M. C., Keith, P., Costello, M., Bradbury, L. A., Hollis, K. A., Thomas, R., Thomas, G. P., Brown, M. A., & Kenna, T. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208677 · Cited by 54
Jiao, Y., Zhang, B., Li, Y., Li, J., Zhang, J., Ma, C., Cui, B., Wang, L., Chen, Z., & Zhao, Y. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9444-z · Cited by 51
Liu, M., Liu, J., Hao, S., Wu, P., Zhang, X., Xiao, Y., Jiang, G., & Huang, X. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4138-7 · Cited by 51
Luci, C., Gaudy‐Marqueste, C., Rouzaire, P., Audonnet, S., Cognet, C., Hennino, A., Nicolas, J., Grob, J., & Tomasello, E. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10814.x · Cited by 49
Hussain, M. J., Alviggi, L., Millward, B. A., Leslie, R. D. G., Pyke, D. A., & Vergani, D. (1987) · Diabetologia · doi:10.1007/bf00295872 · Cited by 49
Rizzo, R., Gentili, V., Casetta, I., Caselli, E., Gennaro, R. D., Granieri, E., Cassai, E., Luca, D. D., & Rotola, A. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.004 · Cited by 47
Activating KIR genes are associated with ankylosing spondylitis in Asian populations
Díaz‐Peña, R., Blanco-Gelaz, M. Á., Suárez-Álvarez, B., Martı́nez-Borra, J., López‐Vázquez, A., Alonso‐Arias, R., Bruges‐Armas, J., Vidal-Castiñeira, J. R., & López‐Larrea, C. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.04.012 · Cited by 47
Immunometabolism in the pathogenesis of systemic lupus erythematosus
Zhang, C., Wang, H., Yin, L., Mao, Y., & Zhou, W. (2020) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2020.100046 · Cited by 45
CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis
Laroni, A., & Uccelli, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051450 · Cited by 43
IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease
Çetin, E. A., Coşan, F., Çefle, A., & Deniz, G. (2014) · Modern Rheumatology · doi:10.3109/14397595.2013.879414 · Cited by 42
Self-citationContribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus
Mackern‐Oberti, J. P., Llanos, C., Riedel, C. A., Bueno, S. M., & Kalergis, A. M. (2015) · Immunology · doi:10.1111/imm.12504 · Cited by 42
Li, W., Pan, H., Hu, J., Wang, C., Zhang, N., Li, J., Li, X.-P., Xu, J., & Ye, D. (2009) · Clinical Rheumatology · doi:10.1007/s10067-009-1322-9 · Cited by 41
Puxeddu, I., Bongiorni, F., CHIMENTI, D., Bombardieri, S., Moretta, A., Bottino, C., & Migliorini, P. (2012) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2011.648657 · Cited by 40
Two to Tango: Dialogue between Adaptive and Innate Immunity in Type 1 Diabetes
Sun, L., Xi, S., He, G., Li, Z., Gang, X., Sun, C., Guo, W., & Wang, G. (2020) · Journal of Diabetes Research · doi:10.1155/2020/4106518 · Cited by 40
Combination of KIR 2DL2 and HLA‐C1 (Asn80) confers susceptibility to type 1 diabetes in Latvians
Shastry, A., Sedimbi, S. K., Rajalingam, R., Nikitina‐Zake, L., Rumba, I., Wigzell, H., & Sanjeevi, C. B. (2008) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2008.00804.x · Cited by 38
Zamai, L., Zotto, G. D., Buccella, F., Gabrielli, S., Canonico, B., Artico, M., Ortolani, C., & Papa, S. (2020) · Cells · doi:10.3390/cells9030753 · Cited by 38
Szántó, S., Aleksza, M., MIHÁLY, E., et al. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.070839 · Cited by 36
The Memories of NK Cells: Innate-Adaptive Immune Intrinsic Crosstalk
Gabrielli, S., Ortolani, C., del Zotto, G., Luchetti, F., Canonico, B., Buccella, F., Artico, M., Papa, S., & Zamai, L. (2016) · Journal of Immunological Research · doi:10.1155/2016/1376595 · Cited by 36
Zeng, X., Chen, H., Gupta, R., Paz‐Altschul, O., Bowcock, A. M., & Liao, W. J. (2013) · Experimental Dermatology · doi:10.1111/exd.12233 · Cited by 34
Impaired IFN-γ production and proliferation of NK cells in Multiple Sclerosis
Lünemann, A., Tackenberg, B., DeAngelis, T. M., da Silva, R. B., Messmer, B., Vanoaica, L. D., Miller, A., Apatoff, B., LUBLIN, F. D., Lünemann, J. D., et al. (2011) · International Immunology · doi:10.1093/intimm/dxq463 · Cited by 34
Overcoming Acquired PD-1/PD-L1 Resistance with CD38 Blockade
Mittal, D., Vijayan, D., & Smyth, M. J. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0798 · Cited by 34
Deficiencies in Gut NK Cell Number and Function Precede Diabetes Onset in BB Rats
Todd, D. J., Forsberg, E. M., Greiner, D. L., Mordes, J. P., Rossini, A. A., & Bortell, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5356 · Cited by 33
Dunphy, S., Sweeney, C. M., Kelly, G. A., Tobin, A., Kirby, B., & Gardiner, C. M. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.10.004 · Cited by 32
Huang, X., Li, J., Dorta-Estremera, S. M., Domizio, J. D., Anthony, S. M., Watowich, S. S., Popkin, D. L., Liu, Z., Brohawn, P. Z., Yao, Y., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.021 · Cited by 32
MICA Gene Polymorphism in the Pathogenesis of Type 1 Diabetes
Gambelunghe, G., Brozzetti, A., Ghaderi, M., Candeloro, P., Tortoioli, C., & Falorni, A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1423.011 · Cited by 32
Fernández-Morera, J. L., Rodríguez‐Rodero, S., Lahoz, C., Tuñon, A., Astudillo, A., García‐Suárez, O., Martı́nez-Borra, J., López‐Vázquez, A., Rodrigo, L., Gonzalez, S. R., et al. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.01.021 · Cited by 32
Lin, S., Kuo, M., Hsiao, H.-S., et al. (2019) · Mediators of Inflammation · doi:10.1155/2019/4236562 · Cited by 31
Yang, C., Siebert, J., Burns, R., Zheng, Y., Mei, A., Bonacci, B. B., Wang, D., Urrutia, R. A., Riese, M. J., Rao, S., et al. (2020) · eLife · doi:10.7554/elife.51339 · Cited by 30
de Lima, J. F., Oliveira, L. M. D. S., Pereira, N. Z., Duarte, A. J. S., & Sato, M. N. (2017) · Scientific Reports · doi:10.1038/s41598-017-00637-3 · Cited by 29
Bosch, G. V. D., Preijers, F. W. M. B., Vreugdenhil, A., Hendriks, J. C. M., Maas, F., & de Witte, T. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03143.x · Cited by 28
Behçet’s Disease: Do Natural Killer Cells Play a Significant Role?
Petrushkin, H., Hasan, M. S., Stanford, M. R., Fortune, F., & Wallace, G. R. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00134 · Cited by 28
Significance of KIR like natural killer cell receptors in autoimmune disorders
Agrawal, S., & Prakash, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108449 · Cited by 28
Aggarwal, A., Sharma, A., & Bhatnagar, A. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2641-z · Cited by 27
Fernández-Morera, J. L., Rodríguez‐Rodero, S., Tunon, A., Martı́nez-Borra, J., Vidal-Castiñeira, J. R., López‐Vázquez, A., Rodrigo, L., Rodrigo, P., Gonzalez, S. R., Lahoz, C., et al. (2008) · Tissue Antigens · doi:10.1111/j.1399-0039.2008.01066.x · Cited by 26
Rastall, D. P. W., Alyaquob, F. S., O’Connell, P. M., Pepelyayeva, Y., Peters, D., Godbehere, S., Pereira‐Hicks, C., Aldhamen, Y. A., & Amalfitano, A. (2017) · International Immunology · doi:10.1093/intimm/dxx035 · Cited by 25
Association of KIR genotype with susceptibility to HLA-B27-positive ankylosing spondylitis
Wang, S., Li, G., Ge, R., Duan, Z., Zeng, Z., Zhang, T., Gao, J., Yang, T., Liu, S., Wu, S., et al. (2012) · Modern Rheumatology · doi:10.1007/s10165-012-0692-z · Cited by 24
Ye, Z., Ma, N., Zhao, L., Jiang, Z., & Jiang, Y. (2014) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12289 · Cited by 22
Elemam, N. M., Hachim, M. Y., Hannawi, S., & Maghazachi, A. A. (2020) · Genes · doi:10.3390/genes11050492 · Cited by 21
Enteroviral Pathogenesis of Type 1 Diabetes: The Role of Natural Killer Cells
Nekoua, M. P., Dechaumes, A., Sané, F., Alidjinou, E. K., Moutairou, K. A., Yessoufou, A., & Hober, D. (2020) · Microorganisms · doi:10.3390/microorganisms8070989 · Cited by 20
Dysfunction of CD3 − CD16 + CD56 dim and CD3 − CD16 − CD56 bright NK cell subsets in RR-MS patients
Tahralı, İ., Küçüksezer, U. C., Altıntaş, A., Uygunoğlu, U., Akdeniz, N., Aktaş-Çetin, E., & Deniz, G. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.02.005 · Cited by 19
Self-citationSystemic and Local Increase of Granulysin Expression in Cytotoxic Lymphocytes in Severe Psoriasis
Vičić, M., Kaštelan, M., Tokmadžić, V. S., & PrpićMassari, L. (2019) · Acta Dermato Venereologica · doi:10.2340/00015555-3298 · Cited by 19
Shastry, A., Sedimbi, S. K., Rajalingam, R., Rumba, I., Kanungo, A. K., & SANJEEVI, C. B. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.058 · Cited by 18
Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet’s disease
Erer, B., Takeuchi, M., Üstek, D., Tuğal-Tutkun, İ., Seyahi, E., Özyazgan, Y., Duymaz-Tozkir, J., Gül, A., Kastner, D. L., Remmers, E. F., et al. (2016) · Genes and Immunity · doi:10.1038/gene.2016.36 · Cited by 18
CD3-CD56+ NK cells display an inflammatory profile in RR-MS patients
Tahralı, İ., Küçüksezer, U. C., Akdeniz, N., Altıntaş, A., Uygunoğlu, U., Aktaş-Çetin, E., & Deniz, G. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.10.006 · Cited by 18
Self-citationNKG 2C, HLA ‐E and their association with psoriasis
Patel, F., Marusina, A. I., Duong, C., Adamopoulos, I. E., & Maverakis, E. (2013) · Experimental Dermatology · doi:10.1111/exd.12280 · Cited by 17
Natural killer cells: versatile roles in autoimmune and infectious diseases
Aktas, E., Erten, G., Küçüksezer, U. C., & Deniz, G. (2009) · Expert Review of Clinical Immunology · doi:10.1586/eci.09.27 · Cited by 17
Self-citationTumor necrosis factor-α enhances IL-15-induced natural killer cell differentiation
Lee, J., Lee, S. H., Shin, N., Jeong, M., Kim, M. S., Kim, M. J., Yoon, S. R., Chung, J. W., Kim, T., & Choi, I. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.120 · Cited by 16
Schulte‐Wrede, U., Sörensen, T., Grün, J. R., Häupl, T., Hirseland, H., Steinbrich‐Zöllner, M., Wu, P., Radbruch, A., Poddubnyy, D., Sieper, J., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1692-y · Cited by 16
Trachtenberg, E. (2009) · Annals of Neurology · doi:10.1002/ana.21747 · Cited by 15
Cauli, A., Dessole, G., Piga, M., Angioni, M. M., Pinna, S., Floris, A., Congia, M., Mascia, E., Paladini, F., Tedeschi, V., et al. (2018) · RMD Open · doi:10.1136/rmdopen-2017-000597 · Cited by 15
Cauli, A., Piga, M., Dessole, G., Porru, G., Floris, A., Vacca, A., Desogus, E., Nasa, G. L., & Mathieu, A. (2014) · Drug Development Research · doi:10.1002/ddr.21187 · Cited by 14
Enciso‐Vargas, M., Alvarado‐Ruíz, L., Suárez-Villanueva, A. S., Macías‐Barragán, J., Montoya‐Buelna, M., Oceguera-Contreras, E., Alvarado‐Navarro, A., & Graciano‐Machuca, O. (2020) · Immunological Investigations · doi:10.1080/08820139.2020.1713145 · Cited by 14
Sakly, K., Lahmar, R., Nefzi, F., Hammami, S. O., Harzallah, O., Sakly, N., Sakly, W., Hassine, M., Mahjoub, S., Ghédira, I., et al. (2014) · Immunological Investigations · doi:10.3109/08820139.2014.886260 · Cited by 9
Chang, Y., Kang, S., Kim, J., Kang, H., & Kim, H. Y. (2017) · Immune Network · doi:10.4110/in.2017.17.5.352 · Cited by 8
Nekoua, M. P., Fachinan, R., Fagninou, A., Alidjinou, E. K., Moutairou, K. A., Hober, D., & Yessoufou, A. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107868 · Cited by 8
Macías‐Barragán, J., Montoya‐Buelna, M., Enciso‐Vargas, M., Alvarado‐Ruíz, L., Oceguera-Contreras, E., Guerra-Rentería, A. S., & Graciano‐Machuca, O. (2020) · Immunological Investigations · doi:10.1080/08820139.2020.1840582 · Cited by 6
Systemic Lupus Erythematosus (SLE)
Nemade, S. V., & Shinde, K. J. (2021) · Springer eBooks · doi:10.1007/978-981-16-4047-6_34 · Cited by 6
Bischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Cited by
Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
Robinson-Agramonte, M. D. L. A., Noris García, E., Fraga Guerra, J., Vega Hurtado, Y., Antonucci, N., Semprún-Hernández, N., Schultz, S., & Siniscalco, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063033 · Cited by 176
Baysac, K., Sun, G., Nakano, H., Schmitz, E. G., Cruz, A. C., Fisher, C., Bailey, A. C., Abbott, J. K., Aldave Becerra, J. C., Allenspach, E. J., et al. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.08.036 · Cited by 63
Biological clock perspective in rheumatoid arthritis
Liu, Q., & Zhang, Y. (2024) · Inflammation · doi:10.1007/s10753-024-02120-4 · Cited by 12
“The crucial role of early innate immune responses in the development of immune-mediated inflammation in general and autoimmunity in particular has received increasing attention [36–38].”
Influential
Metadata
- Authors
- Kucuksezer, U. C., Aktas Cetin, E., Esen, F., Tahrali, I., Akdeniz, N., Gelmez, M. Y., & Deniz, G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-02-25
- Volume
- 12
- Pages
- 622306-622306
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3131639899
- Cited by
- 284
- References
- 283
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.